Filed before 2025Filed 7 September 2021
Asher Biotherapeutics, Inc. raised $108M
Asher Biotherapeutics, Inc., a biotech company based in South San Francisco, CA, raised $108M in a new equity round, according to a filing dated 7 September 2021.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 7 September 2021
- Round
- Equity round
- Amount sold
- $108M
- Offering size
- $108M
- Investors so far
- 22
- Based in
- South San Francisco, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 92% of the 2,220 tracked raises with an amount filed in 2021, and than 86% of the 177 in biotech.
Asher Biotherapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 16 Apr 2024 | New filing | $55M | Another raise |
| 7 Sep 2021 | New filing | $108M | This raise |
More with Third Rock Ventures on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.